Trans-Resveratrol downregulates Txnip overexpression occurring during liver ischemia-reperfusion

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 28, Issue SUPPL. 3, 2010, Pages 1766-1771

  Nivet Antoine, Valérie ^a,b   Cottart, Charles Henry ^a,b   Lemaréchal, Hervé ^c   Vamy, Michel ^a   Margaill, Isabelle ^a   Beaudeux, Jean Louis ^a,b   Bonnefont Rousselot, Dominique ^a,c   Borderie, Didier ^a,c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL CHARLES FOIX   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Hepatoprotection; Oxidative stress; Polyphenol; Thioredoxin; VDUP 1

Indexed keywords

DIMETHYLARGININASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RESVERATROL; THIOREDOXIN 1; THIOREDOXIN 2; THIOREDOXIN INTERACTING PROTEIN; THIOREDOXIN REDUCTASE; NITROGEN OXIDE; THIOREDOXIN; TRANS RESVERATROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; LIVER; LIVER ISCHEMIA; LIVER PROTECTION; MALE; NONHUMAN; OXIDATION REDUCTION REACTION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; REPERFUSION; DOWN REGULATION; GENE OVEREXPRESSION; REPERFUSION INJURY;

AMIDOHYDROLASES; ANIMALS; ANTIOXIDANTS; BLOTTING, WESTERN; CARRIER PROTEINS; DOWN-REGULATION; INJECTIONS, INTRAVENOUS; LIVER; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; OXIDATION-REDUCTION; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; STILBENES; THIOREDOXIN-DISULFIDE REDUCTASE; THIOREDOXINS;

EID: 78649833040     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/j.biochi.2010.07.018     Document Type: Article

References (28)

1. S.Y. Kim, H.W. Suh, J.W. Chung, S.R. Yoon, and I. Choi Diverse functions of VDUP1 in cell proliferation, differentiation, and diseases Cell Mol. Immunol. 4 2007 345 351
2. P. Patwari, W.A. Chutkow, K. Cummings, V.L. Verstraeten, J. Lammerding, E.R. Schreiter, and R.T. Lee Thioredoxin-independent regulation of metabolism by the alpha-arrestin proteins J. Biol. Chem. 284 2009 24996 25003
3. A.M. Kaimul, H. Nakamura, H. Masutani, and J. Yodoi Thioredoxin and thioredoxin-binding protein-2 in cancer and metabolic syndrome Free Radic. Biol. Med. 43 2007 861 868
4. W.A. Chutkow, P. Patwari, J. Yoshioka, and R.T. Lee Thioredoxin- interacting protein (Txnip) is a critical regulator of hepatic glucose production J. Biol. Chem. 283 2008 2397 2406
5. T. Yoshida, N. Kondo, S. Oka, M.K. Ahsan, T. Hara, H. Masutani, H. Nakamura, and J. Yodoi Thioredoxin-binding protein-2 (TBP-2): its potential roles in the aging process Biofactors 27 2006 47 51
6. J. Chen, G. Saxena, I.N. Mungrue, A.J. Lusis, and A. Shalev Thioredoxin-interacting protein: a critical link between glucose toxicity and beta-cell apoptosis Diabetes 57 2008 938 944
7. J. Chen, G. Fontes, G. Saxena, V. Poitout, and A. Shalev Lack of TXNIP protects against mitochondria-mediated apoptosis but not against fatty acid-induced ER stress-mediated beta-cell death Diabetes 59 2010 440 447
8. A. Shalev Lack of TXNIP protects beta-cells against glucotoxicity Biochem. Soc. Trans. 36 2008 963 965
9. X. Li, Y. Rong, M. Zhang, X.L. Wang, S.A. LeMaire, J.S. Coselli, Y. Zhang, and Y.H. Shen Up-regulation of thioredoxin interacting protein (Txnip) by p38 MAPK and FOXO1 contributes to the impaired thioredoxin activity and increased ROS in glucose-treated endothelial cells Biochem. Biophys. Res. Commun. 381 2009 660 665
10. H. Okuyama, A. Son, M.K. Ahsan, H. Masutani, H. Nakamura, and J. Yodoi Thioredoxin and thioredoxin binding protein 2 in the liver IUBMB Life 60 2008 656 660
11. H. Jaeschke Mechanisms of Liver Injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions Am. J. Physiol. Gastrointest. Liver Physiol. 290 2006 G1083 G1088
12. J.A. Baur, and D.A. Sinclair Therapeutic potential of resveratrol: the in vivo evidence Nat. Rev. Drug Discov. 5 2006 493 506
13. C. Plin, J.P. Tillement, A. Berdeaux, and D. Morin Resveratrol protects against cold ischemia-warm reoxygenation-induced damages to mitochondria and cells in rat liver Eur. J. Pharmacol. 528 2005 162 168
14. G. Notas, A.P. Nifli, M. Kampa, J. Vercauteren, E. Kouroumalis, and E. Castanas Resveratrol exerts its antiproliferative effect on HepG2 hepatocellular carcinoma cells, by inducing cell cycle arrest, and NOS activation Biochim. Biophys. Acta 1760 2006 1657 1666
15. S. Hassan-Khabbar, C.H. Cottart, D. Wendum, F. Vibert, J.P. Clot, J.F. Savouret, M. Conti, and V. Nivet-Antoine Postischemic treatment by trans-resveratrol in rat liver ischemia-reperfusion: a possible strategy in liver surgery Liver Transpl. 14 2008 451 459
16. J. Dudley, S. Das, S. Mukherjee, and D.K. Das Resveratrol, a unique phytoalexin present in red wine, delivers either survival signal or death signal to the ischemic myocardium depending on dose J. Nutr. Biochem. 20 2009 443 452
17. M.T. Forrester, D. Seth, A. Hausladen, C.E. Eyler, M.W. Foster, A. Matsumoto, M. Benhar, H.E. Marshall, and J.S. Stamler Thioredoxin-interacting protein (Txnip) is a feedback regulator of S-nitrosylation J. Biol. Chem. 284 2009 36160 36166
18. P.C. Schulze, H. Liu, E. Choe, J. Yoshioka, A. Shalev, K.D. Bloch, and R.T. Lee Nitric oxide-dependent suppression of thioredoxin-interacting protein expression enhances thioredoxin activity Arterioscler. Thromb. Vasc. Biol. 26 2006 2666 2672
19. C.H. Cottart, L. Do, M.C. Blanc, M. Vaubourdolle, G. Descamps, D. Durand, F.X. Galen, and J.P. Clot Hepatoprotective effect of endogenous nitric oxide during ischemia-reperfusion in the rat Hepatology 29 1999 809 813
20. S. Hassan-Khabbar, M. Vamy, C.H. Cottart, D. Wendum, F. Vibert, J.F. Savouret, P. Therond, J.P. Clot, A.J. Waligora, and V. Nivet-Antoine Protective effect of post-ischemic treatment with trans-resveratrol on cytokine production and neutrophil recruitment by rat liver Biochimie 92 2010 405 410
21. L.C. Green, D.A. Wagner, J. Glogowski, P.L. Skipper, J.S. Wishnok, and S.R. Tannenbaum Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids Anal. Biochem. 126 1982 131 138
22. E.S. Arner, L. Zhong, and A. Holmgren Preparation and assay of mammalian thioredoxin and thioredoxin reductase Methods Enzymol. 300 1999 226 239
23. M. Knipp, and M. Vasak A colorimetric 96-well microtiter plate assay for the determination of enzymatically formed citrulline Anal. Biochem. 286 2000 257 264
24. J. Chen, H. Cha-Molstad, A. Szabo, and A. Shalev Diabetes induces and calcium channel blockers prevent cardiac expression of proapoptotic thioredoxin-interacting protein Am. J. Physiol. Endocrinol. Metab. 296 2009 E1133 E1139
25. L. Billiet, and M. Rouis Thioredoxin-1 is a novel and attractive therapeutic approach for various diseases including cardiovascular disorders Cardiovasc. Hematol. Disord. Drug Targets 8 2008 293 296
26. V. Eybl, D. Kotyzova, and J. Koutensky Comparative study of natural antioxidants - curcumin, resveratrol and melatonin - in cadmium-induced oxidative damage in mice Toxicology 225 2006 150 156
27. H. Rivera, M. Shibayama, V. Tsutsumi, V. Perez-Alvarez, and P. Muriel Resveratrol and trimethylated resveratrol protect from acute liver damage induced by CCl4 in the rat J. Appl. Toxicol. 28 2008 147 155
28. A. Fard, C.H. Tuck, J.A. Donis, R. Sciacca, M.R. Di Tullio, H.D. Wu, T.A. Bryant, N.T. Chen, M. Torres-Tamayo, R. Ramasamy, L. Berglund, H.N. Ginsberg, S. Homma, and P.J. Cannon Acute elevations of plasma asymmetric dimethylarginine and impaired endothelial function in response to a high-fat meal in patients with type 2 diabetes Arterioscler. Thromb. Vasc. Biol. 20 2000 2039 2044